Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Sep-23 4:24 PM View:  | Nochur Sara Director | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 25-Sep-23 4:28 PM View: | McLaughlin Kevin F Director | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 25-Sep-23 4:32 PM View: | Carson William H. Director | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 25-Sep-23 4:24 PM View: | Kapusta Matthew C Director | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 25-Sep-23 4:29 PM View: | Finger Alison Cecily Director | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 25-Sep-23 4:35 PM View: | Trask Anna Chief People Officer | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 106,864 | -- | -- | (100%) 106.86K to 0 | |
| 25-Sep-23 4:25 PM View: | Reid Laurence See Remarks Director | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 220,849 | -- | -- | (100%) 220.85K to 0 | |
| 25-Sep-23 4:30 PM View: | Lee John Jui-Jen Chief Development Officer | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 147,144 | -- | -- | (100%) 147.14K to 0 | |
| 14-Jun-23 4:40 PM View: | Finger Alison Cecily Director | Decibel Therapeutics, Inc. (DBTX) | 13-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 14-Jun-23 4:42 PM View: | Carson William H. Director | Decibel Therapeutics, Inc. (DBTX) | 13-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 14-Jun-23 4:37 PM View: | McLaughlin Kevin F Director | Decibel Therapeutics, Inc. (DBTX) | 13-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 14-Jun-23 4:44 PM View: | Nochur Sara Director | Decibel Therapeutics, Inc. (DBTX) | 13-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 21-Mar-23 4:13 PM View: | Kapusta Matthew C Director | Decibel Therapeutics, Inc. (DBTX) | 19-Mar-23 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 17-Mar-23 4:24 PM View: | Reid Laurence See Remarks Director | Decibel Therapeutics, Inc. (DBTX) | 16-Mar-23 | Grant | 195,000 | -- | -- | 754% 25.85K to 220.85K | |
| 30-Jan-23 5:26 PM View: | Lee John Jui-Jen Chief Development Officer | Decibel Therapeutics, Inc. (DBTX) | 26-Jan-23 | Grant | 120,000 | -- | -- | 442% 27.14K to 147.14K | |
| 30-Jan-23 5:28 PM View: | Trask Anna Chief People Officer | Decibel Therapeutics, Inc. (DBTX) | 26-Jan-23 | Grant | 105,000 | -- | -- | 5633% 1.86K to 106.86K | |
| 04-Jan-22 4:12 PM View: | Trask Anna See Remarks | Decibel Therapeutics, Inc. (DBTX) | 03-Jan-22 | Market Sale (Planned) | 378 | $5.03 | $1,901.35 | (17%) 2.24K to 1.86K | < 1% |
| 06-Dec-21 4:20 PM View: | Trask Anna See Remarks | Decibel Therapeutics, Inc. (DBTX) | 02-Dec-21 | Market Sale (Planned) | 5,291 | $6.37 | $33,688.10 | (70%) 7.53K to 2.24K | 3% |
| 04-Nov-21 8:00 AM View: | Trask Anna See Remarks | Decibel Therapeutics, Inc. (DBTX) | 03-Nov-21 | Market Sale (Planned) | 378 | $8.34 | $3,152.22 | (5%) 7.91K to 7.53K | (< 1%) |
| 03-Nov-21 4:16 PM View: | Trask Anna See Remarks | Decibel Therapeutics, Inc. (DBTX) | 02-Nov-21 | Market Sale (Planned) | 4,913 | $8.31 | $40,827.00 | (38%) 12.82K to 7.91K | (1%) |
| 15-Oct-21 4:57 PM View: | Trask Anna See Remarks | Decibel Therapeutics, Inc. (DBTX) | 14-Oct-21 | Market Sale (Planned) | 5,364 | $7.55 | $40,481.00 | (29%) 18.19K to 12.82K | < 1% |
| 17-Feb-21 7:42 PM View: | Gv 2017 Gp, L.L.C. 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 494,649 | -- | -- | 100% 0 to 494.65K | |
| 18-Feb-21 5:40 PM View: | Longevity Fund 2 Lp 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 79,143 | -- | -- | 100% 0 to 79.14K | |
| 19-Feb-21 6:50 PM View: | Thompson Peter A Director 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 3,278,530 | -- | -- | 100% 0 to 3.28M | |
| 19-Feb-21 7:09 PM View: | Orbimed Advisors LLC Director 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion Duplicate | 3,278,530 | -- | -- | 100% 0 to 3.28M | |
| 19-Feb-21 6:50 PM View: | Thompson Peter A Director 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Purchase | 1,666,670 | $18.00 | $30,000,000.00 | 51% 3.28M to 4.95M | |
| 19-Feb-21 7:09 PM View: | Orbimed Advisors LLC Director 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Purchase Duplicate | 1,666,670 | $18.00 | $30,000,000.00 | 51% 3.28M to 4.95M | |
| 17-Feb-21 7:45 PM View: | Gv 2019 Gp, L.L.C. 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 819,631 | -- | -- | 100% 0 to 819.63K | |
| 19-Feb-21 4:50 PM View: | Glaxosmithkline Plc Director | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 1,033,660 | -- | -- | 100% 0 to 1.03M | |
| 19-Feb-21 6:56 PM View: | Casdin Partners Master Fund... 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 546,421 | -- | -- | 100% 0 to 546.42K | |
| 08-Mar-21 5:35 PM View: | Schroder Adveq Technology I... 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 1,048,660 | -- | -- | 100% 0 to 1.05M | |
| 19-Feb-21 6:56 PM View: | Casdin Partners Master Fund... 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Purchase | 575,000 | $18.00 | $10,350,000.00 | 105% 546.42K to 1.12M | |
| 17-Feb-21 7:38 PM View: | Gv 2016 Gp, L.L.C. 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 321,978 | -- | -- | 100% 0 to 321.98K | |
| 18-Feb-21 4:01 PM View: | Regeneron Pharmaceuticals Inc 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 2,097,310 | -- | -- | 100% 0 to 2.1M | |
| 19-Feb-21 6:50 PM View: | Exter Neil Director 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 3,092,520 | -- | -- | 6556% 47.16K to 3.14M | |
| 19-Feb-21 6:59 PM View: | Foy Matthew Director 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion Duplicate | 1,033,660 | -- | -- | 100% 0 to 1.03M | |
| 19-Feb-21 4:50 PM View: | Glaxosmithkline Plc Director | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Purchase | 150,000 | $18.00 | $2,700,000.00 | 15% 1.03M to 1.18M | |
| 19-Feb-21 6:59 PM View: | Foy Matthew Director 10% Owner | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Purchase Duplicate | 150,000 | $18.00 | $2,700,000.00 | 15% 1.03M to 1.18M |
